Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- cefaleia episódica intenso
- náuseas e vômitos
- sensibilidade à luz e a ruídos
- impacto funcional
- sintomas de aura
- sensação latejante
Факторы риска
- história familiar de enxaqueca
- sexo feminino e alterações hormonais
- má qualidade do sono
- estresse
- uso excessivo de medicamentos
- síndromes periódicas
Диагностические исследования
Исследования, которые показаны в первую очередь
- diagnóstico clínico
Исследования, проведение которых нужно рассмотреть
- ressonância nuclear magnética (RNM) cranioencefálica
- eletroencefalograma
- punção lombar
- velocidade de hemossedimentação (VHS) e proteína C-reativa
- tomografia computadorizada (TC) de crânio
Алгоритм лечения
episódio agudo
≥1 enxaqueca significativa por semana
Составители
Авторы
Cristian Ionita, MD
Associate Professor of Clinical Pediatrics (Neurology)
Yale School of Medicine
New Haven
CT
Раскрытие информации
CI declares that he has no competing interests.
Выражение благодарностей
Dr Christian Ionita would like to gratefully acknowledge Dr Nick Barnes, a previous contributor to this topic.
Раскрытие информации
NB declares that he has no competing interests.
Рецензенты
Kenneth Mack, MD, PhD
Medical Director
Mayo Clinic Pediatric Center
Rochester
MN
Раскрытие информации
KM declares that he has no competing interests.
Tony McShane, MBBS
Consultant Paediatric Neurologist
John Radcliffe Hospital
Oxford
UK
Раскрытие информации
TM declares that he has no competing interests.
Sandeep Jayawant, MBBS
Consultant Paediatric Neurologist
John Radcliffe Hospital
Oxford
UK
Раскрытие информации
SJ declares that he has no competing interests.
Howard S. Jacobs, MD
Associate Professor
Co-Director Pediatric Headache Clinic
University of Maryland School of Medicine
Baltimore
MD
Раскрытие информации
HSJ declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.Полный текст Аннотация
Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):500-9.Полный текст Аннотация
Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: acute treatment of migraine in children and adolescents. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019 Sep 10;93(11):487-99.Полный текст Аннотация
Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016 Apr 19;(4):CD005220.Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Отличия
- Cefaleia tensional
- Cefaleia por uso excessivo de medicamentos
- Cefaleia pós-traumática
Больше ОтличияРекомендации
- Practice guideline update: acute treatment of migraine in children and adolescents
- Practice guideline update: pharmacologic treatment for pediatric migraine prevention
Больше РекомендацииЛифлеты для пациента
Enxaqueca em crianças
Enxaqueca em crianças: medicamentos para prevenir as crises
Больше Лифлеты для пациентаВойдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности